Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot

  • David Simmons
    Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, U.K.
  • Judith G.M. Jelsma
    Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
  • Sander Galjaard
    KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
  • Roland Devlieger
    KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
  • Andre van Assche
    KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
  • Goele Jans
    KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
  • Rosa Corcoy
    Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  • Juan M. Adelantado
    Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  • Fidelma Dunne
    National University of Ireland, Galway, Ireland
  • Gernot Desoye
    Department of Obstetrics and Gynecology, Medizinische Universitaet Graz, Graz, Austria
  • Jürgen Harreiter
    Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
  • Alexandra Kautzky-Willer
    Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
  • Peter Damm
    Center for Pregnant Women with Diabetes, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  • Elisabeth R. Mathiesen
    Center for Pregnant Women with Diabetes, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  • Dorte M. Jensen
    Odense University Hospital, Odense, Denmark
  • Lise Lotte Andersen
    Odense University Hospital, Odense, Denmark
  • Annunziata Lapolla
    Universita Degli Studi di Padova, Padua, Italy
  • Maria Dalfra
    Universita Degli Studi di Padova, Padua, Italy
  • Alessandra Bertolotto
    Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
  • Ewa Wender-Ozegowska
    Department of Obstetrics and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland
  • Agnieszka Zawiejska
    Department of Obstetrics and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland
  • David Hill
    Recherche en Santé Lawson SA, Bronschhofen, Switzerland
  • Pablo Rebollo
    BAP Health Outcomes Research SL, Oviedo, Spain
  • Frank J. Snoek
    Department of Medical Psychology, VU University Medical Center and Academic Medical Center, Amsterdam, the Netherlands
  • Mireille N.M. van Poppel
    Department of Public and Occupational Health, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands

説明

<jats:sec> <jats:title>OBJECTIVE</jats:title> <jats:p>Ways to prevent gestational diabetes mellitus (GDM) remain unproven. We compared the impact of three lifestyle interventions (healthy eating [HE], physical activity [PA], and both HE and PA [HE+PA]) on GDM risk in a pilot multicenter randomized trial.</jats:p> </jats:sec> <jats:sec> <jats:title>RESEARCH DESIGN AND METHODS</jats:title> <jats:p>Pregnant women at risk for GDM (BMI ≥29 kg/m2) from nine European countries were invited to undertake a 75-g oral glucose tolerance test before 20 weeks' gestation. Those without GDM were randomized to HE, PA, or HE+PA. Women received five face-to-face and four optional telephone coaching sessions, based on the principles of motivational interviewing. A gestational weight gain (GWG) &lt;5 kg was targeted. Coaches received standardized training and an intervention toolkit. Primary outcome measures were GWG, fasting glucose, and insulin sensitivity (HOMA) at 35–37 weeks.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>Among the 150 trial participants, 32% developed GDM by 35–37 weeks and 20% achieved GWG &lt;5 kg. HE women had less GWG (−2.6 kg [95% CI −4.9, −0.2]; P = 0.03) and lower fasting glucose (−0.3 mmol/L [−0.4, −0.1]; P = 0.01) than those in the PA group at 24–28 weeks. HOMA was comparable. No significant differences between HE+PA and the other groups were observed.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS</jats:title> <jats:p>An antenatal HE intervention is associated with less GWG and lower fasting glucose compared with PA alone. These findings require a larger trial for confirmation but support the use of early HE interventions in obese pregnant women.</jats:p> </jats:sec>

収録刊行物

  • Diabetes Care

    Diabetes Care 38 (9), 1650-1656, 2015-06-25

    American Diabetes Association

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ